Literature DB >> 15717875

Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance.

N A Abdella1, O A Mojiminiyi, M A Moussa, M Zaki, H Al Mohammedi, E S S Al Ozairi, S Al Jebely.   

Abstract

AIMS: The aim of this study was to evaluate the relationship of obesity, leptin, insulin resistance and C-reactive protein (CRP) with coronary heart disease (CHD) risk factors in patients with Type 2 diabetes mellitus (DM) with CHD compared with those with Type 2 DM without CHD.
METHODS: Leptin, CRP (high sensitivity assay), fasting plasma insulin, glucose, HbA(1c) and full lipid profile were determined in 58 Type 2 diabetic patients with CHD and 87 Type 2 DM patients without CHD.
RESULTS: were compared between those with and without CHD. Univariate correlation as well as logistic regression analyses were used to relate these markers with traditional CHD risk factors.
RESULTS: Leptin showed significant correlations with BMI (r = 0.59; P < or = 0.0001), waist circumference (r = 0.45; P < 0.0001), CRP (r = 0.36; P < 0.0001), and fasting insulin (r = 0.53; P < 0.0001) as well as with systolic (r = 0.23; P = 0.007) and diastolic (r = 0.23; P = 0.007) blood pressure. However, when those with and without CHD were compared only age (P < 0.0001), duration of diabetes (P < 0.001) and degree of microalbuminuria (P = 0.02) were significantly higher in patients with CHD. Leptin (P = 0.49), CRP (P = 0.19) and lipid parameters were not significantly different between the two groups.
CONCLUSION: Our study confirms a relationship between leptin and CRP with CHD risk factors. The lack of significant difference when patients with and without CHD are compared may be due to the potential confounding effects of treatment with aspirin and statins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717875     DOI: 10.1111/j.1464-5491.2004.01405.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

2.  The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity.

Authors:  D A de Luis; R Aller; O Izaola; H F Ovalle
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

3.  Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

Authors:  Sema Uslu; Nur Kebapçi; Mehmet Kara; Cengiz Bal
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

4.  The metabolic profile in patients with skin tags.

Authors:  Ramazan Sari; Ayse Akman; Erkan Alpsoy; Mustafa Kemal Balci
Journal:  Clin Exp Med       Date:  2009-12-24       Impact factor: 3.984

5.  Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus.

Authors:  Tove Lekva; Annika Elisabet Michelsen; Pål Aukrust; Tore Henriksen; Jens Bollerslev; Thor Ueland
Journal:  Cardiovasc Diabetol       Date:  2017-01-10       Impact factor: 9.951

6.  Assessment of Patients with Periorbital Melanosis for Hyperinsulinemia and Insulin Resistance.

Authors:  Devinder M Thappa; Laxmisha Chandrashekar; Medha Rajappa; R Usha; K Muthupandi; Palani S Mohanraj; Malathi Munisamy; Nidhi Singh
Journal:  Indian Dermatol Online J       Date:  2021-03-02

7.  Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.

Authors:  Min Hi Park; Ji Young Park; Hye Jin Lee; Dae Hyun Kim; Daeui Park; Hyoung Oh Jeong; Chan Hum Park; Pusoon Chun; Hyung Ryong Moon; Hae Young Chung
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

8.  Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.

Authors:  Clarisse Noël A Ayina; Jean Jacques N Noubiap; Laurent Serge Etoundi Ngoa; Philippe Boudou; Jean François Gautier; Michel Karngong Mengnjo; Jean Claude Mbanya; Eugene Sobngwi
Journal:  Lipids Health Dis       Date:  2016-05-17       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.